TIL · NASDAQ
Instil Bio (TIL) Stock Price & Fundamentals
Instil Bio (TIL) closed at $219.33 on Oct 9, 2026, up 1.27% from the previous close of $216.58.
Share price, past year
1Y +18.95%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $219.33 |
| Sep 30, 2026 | $214.47 |
| Aug 31, 2026 | $208.60 |
| Jul 31, 2026 | $220.24 |
| Jun 30, 2026 | $213.49 |
| May 29, 2026 | $220.30 |
| Apr 30, 2026 | $216.48 |
| Mar 31, 2026 | $214.18 |
| Feb 27, 2026 | $208.38 |
| Jan 30, 2026 | $203.88 |
| Dec 31, 2025 | $193.78 |
| Nov 28, 2025 | $197.25 |
| Oct 31, 2025 | $188.97 |
Key statistics
- Market cap
- $1.49B
- P/E (TTM)
- —
- EPS (TTM)
- −$4.39
- Revenue (TTM)
- —
- Net income (TTM)
- −$30.28M
- Shares outstanding
- 6.8M
- Dividend yield
- —
- 52-week range
- $182.76 – $227.50
Instil Bio's market cap is $1.49B, based on a share price of $219.33 and 6.8M shares outstanding as of Jun 30, 2026.
Financials
Instil Bio reported revenue of $0.00 for fiscal 2021, down 100.00% from fiscal 2020.
Instil Bio reported a net loss of $71.37M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2021ended Dec 31, 2021 | $0.00 | −100.0% | −$156.79M | — | −$29.60 | −$179.97M |
| FY2020ended Dec 31, 2020 | $138.00K | — | −$37.74M | −27,346.4% | −$47.20 | −$80.43M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2021ended Dec 31, 2021 | $0.00 | — | — |
| Q3 FY2021ended Sep 30, 2021 | $0.00 | — | — |
| Q2 FY2021ended Jun 30, 2021 | $0.00 | — | — |
| Q1 FY2021ended Mar 31, 2021 | $0.00 | — | — |
| Q4 FY2020ended Dec 31, 2020 | $0.00 | — | — |
| Q3 FY2020ended Sep 30, 2020 | $52.00K | — | — |
| Q2 FY2020ended Jun 30, 2020 | $42.00K | — | — |
| Q1 FY2020ended Mar 31, 2020 | $44.00K | — | — |
Company profile
- Name
- Instil Bio, Inc.
- Ticker
- TIL
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 3963 Maple Avenue, Suite 350, Dallas, TX 75219
- Incorporated in
- NY
- Fiscal year ends
- December
- SEC CIK
- 0001789769
Recent SEC filings
- Aug 13, 2026
- Aug 13, 2026
- Jun 11, 2026
- May 15, 2026
- May 15, 2026
- Apr 3, 2026
- Mar 27, 2026
- Mar 27, 2026
Frequently asked questions
What is Instil Bio's stock price?
Instil Bio (TIL) closed at $219.33 on Oct 9, 2026, up 1.27% from the previous close of $216.58.
What is Instil Bio's market cap?
Instil Bio's market cap is $1.49B, based on a share price of $219.33 and 6.8M shares outstanding as of Jun 30, 2026.
How much revenue does Instil Bio make?
Instil Bio reported revenue of $0.00 for fiscal 2021, down 100.00% from fiscal 2020.
Does Instil Bio pay a dividend?
Instil Bio's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Instil Bio, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures